Irene founded Everest and served as the company’s CEO for more than twenty years until February 2025. In her current role as Founder and Executive Chairman, Irene continues to provide strategic advisory, and operational planning and support for Everest’s long-term business strategy. Irene’s over three decades of experience in pharmaceutical new drug development, clinical research…

Jin Dai is the Chief Executive Officer (CEO) and a Board Member of Everest. A transformational leader at Everest for more than a decade, she has led strong organizational growth and exceptional execution across the business. She provides strategic, data-driven leadership, directs business analysis, empowers cross-functional teams to deliver results, and spearheads strong sales and…

Rob Woolson has more than 18 years’ leadership and technical delivery experience in providing clinical research services to pharmaceutical and biotech companies through all phases of clinical development. He is a multi-disciplinary leader who is versed in leading biometrics (biostatistics, statistical programming, data management and clinical data standards), regulatory strategy and submission, and technology innovation…

Ghazala Parvez joined Everest in 2021 as the Chief Financial Officer. She has over 30 years of experience in financial management roles. Prior to joining Everest, Ghazala has held Chief Financial Officer roles at Nulogy Corporation, Intelex Technologies Inc., and Adenyo Inc.   Ghazala began her financial career at Ernst & Young and has since worked in financial…

Amy Nguyen is a seasoned commercial and business development leader with more than 20 years of experience driving growth, expanding market presence, and building trusted partnerships across the clinical research and life sciences industries. As Chief Commercial Officer at Everest, Amy leads the company’s global commercial strategy, supporting clients from the earliest stages of engagement…

Dana has over 20 years of experience in the CRO industry. She was the CEO and co-founder of August Research, prior to its acquisition by Everest in November 2023. Dana co-founded August Research in 2012 to provide high quality clinical operations services in Europe for small and medium biopharmaceutical companies. Under her leadership, she expanded…

Lukasz Niedzielski has over 15 years of experience in the CRO industry. He was the CFO and co-founder of August Research, prior to its acquisition by Everest in November 2023. Prior to August Research, Lukasz was a Finance Director at PPD, which he joined through its acquisition of AbCRO, where he was CFO from 2006.…

Grant La Hay has more than 30 years of experience in the pharmaceutical and clinical research fields and has accelerated from supervisory to management positions held in human resources (HR) for 15 years. Over the past 15 years of performing in strategic HR leadership roles, Grant has demonstrated strong leadership initiatives driving business success. Grant…